|
88
|
245
|
5krmA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with the a-cd ring estrogen, (1s,7as)-5-(2,5-difluoro-4-hydroxyphenyl)-7a-methyl-2,3,3a,4,7,7a-hexahydro-1h-inden-1-ol |
|
92
|
237
|
5l11A |
Human liver receptor homologue-1 (lrh-1) bound to rjw100 and a fragment of tif-2 |
|
80
|
240
|
5jy3A |
Crystal structure of lxrbeta (nuclear receptor subfamily 1, group h, member 2) complexed with bms-852927 |
|
88
|
244
|
5kd9A |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with an n-trifluoroethyl 4-chlorobenzyl obhs-n derivative |
|
88
|
227
|
5k74A |
Crystal structure of retinoic acid receptor-related orphan receptor (ror) gamma ligand binding domain complex with sbi0655870 |
|
98
|
252
|
5jjmA |
Crystal structure of homodimeric androgen receptor ligand-binding domain bound to dht and lxxll peptide |
|
87
|
245
|
5kcwA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with an n-trifluoroethyl obhs-n derivative |
|
81
|
244
|
5kccA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with oxabicyclic heptene sulfonamide (obhs-n) |
|
87
|
243
|
5jmmA |
Crystal structure of hera-lbd (y537s) in complex with biochanin a |
|
91
|
246
|
5kctA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with an n-ethyl, 4-chlorobenzyl obhs-n derivative |
|
92
|
235
|
5k13A |
Crystal structure of the rar alpha ligand-binding domain in complex with an antagonist |
|
79
|
229
|
5ji0A |
Ppargamma-rxralpha(s427f) heterodimer in complex with src-1, rosiglitazone, and 9-cis-retanoic acid |
|
82
|
243
|
5kcuA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with an n-ethyl, alpha-naphthyl obhs-n derivative |
|
85
|
247
|
5kceA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with an n-methyl, 2-chlorobenzyl obhs-n derivative |
|
99
|
251
|
5jjmB |
Crystal structure of homodimeric androgen receptor ligand-binding domain bound to dht and lxxll peptide |
|
92
|
244
|
5kcdA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with an n-methyl substituted obhs-n derivative |
|
90
|
247
|
5kcfA |
Crystal structure of the er-alpha ligand-binding domain (y537s) in complex with an n-ethyl, 4-methoxybenzyl obhs-n derivative |
|
90
|
228
|
5iawA |
Novel natural fxr modulator with a unique binding mode |
|
102
|
260
|
5i4vA |
Discovery of novel, orally efficacious liver x receptor (lxr) beta agonists |
|
82
|
247
|
5i4vB |
Discovery of novel, orally efficacious liver x receptor (lxr) beta agonists |
|
85
|
243
|
5hyrA |
Estrogen receptor alpha ligand binding domain y537s mutant in complex with stapled peptide src2-sp2 and estradiol |
|
96
|
267
|
5hykA |
Crystal structure of the complex pparalpha/al26-29 |
|
95
|
268
|
5hzcA |
Crystal structure of the complex ppargamma/al26-29 |
|
89
|
250
|
5h1eA |
Interaction between vitamin d receptor and coactivator peptide src2-3 |
|
98
|
261
|
5hjpB |
Identification of lxrbeta selective agonists for the treatment of alzheimer's disease |
|
72
|
250
|
5hjpA |
Identification of lxrbeta selective agonists for the treatment of alzheimer's disease |
|
107
|
276
|
5gtnA |
Human ppargamma ligand binding dmain complexed with r35 |
|
74
|
195
|
5gymA |
Crystal structure of rxr-lbd complexed with fluorescent ligand at 2.60 angstroms resolution |
|
98
|
272
|
4ci5A |
Structural basis for gl479 a dual peroxisome proliferator-activated receptor gamma agonist |
|
95
|
245
|
6g05A |
Rorgt (264-518;c455s) in complex with inverse agonist "cpd-2" and rip140 peptide at 1.90a |
|
92
|
245
|
6fzuA |
Rorgt (264-518;c455s) in complex with the fragment ("cpd-1") and rip140 peptide at 1.80a |
|
100
|
245
|
6g07A |
Rorgt (264-518;c455s) in complex with inverse agonist "cpd-9" and rip140 peptide at 1.66a |
|
96
|
238
|
6fx0A |
Structure-based design of trifarotene (cd5789), a potent and selective rar gamma agonist for the treatment of acne |
|
94
|
298
|
6fobA |
Vitamin d receptor complex 5 |
|
97
|
299
|
6fodA |
Vitamin d nuclear receptor complex 1 |
|
99
|
299
|
6fo7A |
Vitamin d nuclear receptor complex 3 |
|
91
|
296
|
6fo81 |
Vitamin d nuclear receptor complex 4 |
|
99
|
299
|
6fo9A |
Vitamin d nuclear receptor complex 2 |
|
87
|
231
|
6fgqA |
Ligand complex of rorg lbd |
|
93
|
268
|
6f2lA |
Crystal structure of the complex between ppargamma lbd and the ligand lj570: structure obtained from crystals of the apo-form soaked for 15 days. |
|
97
|
272
|
6enqA |
Structure of human ppar gamma lbd in complex with lanifibranor (iva337) |
|
100
|
252
|
6esnA |
Ligand complex of rorg lbd |
|
95
|
247
|
6el9A |
Glucocorticoid receptor in complex with azd9567 |
|
97
|
247
|
6el6A |
Glucocorticoid receptor in complex with compound 4 |
|
86
|
247
|
6dxkA |
Glucocorticoid receptor in complex with compound 11 |
|
98
|
247
|
6el7A |
Glucocorticoid receptor in complex with compound 31 |
|
110
|
317
|
6dupA |
Crystal structure of pxr in complex with compound 7 |
|
85
|
276
|
6c5tA |
Pparg lbd bound to sr11023 |
|
81
|
227
|
6cvhA |
Identification and biological evaluation of thiazole-based inverse agonists of rorgt |
|
87
|
246
|
6chwA |
Estrogen receptor alpha y537s covalently bound to antagonist h3b-5942. |
